Individuals who developed type 1 diabetes (T1D) in adulthood faced a higher risk for all-cause mortality and major adverse cardiovascular events (MACEs) than individuals from the general population ...

Oral semaglutide is now approved to reduce cardiovascular risk in high-risk type 2 diabetes patients, marking a first for oral GLP-1 receptor agonists. The SOUL trial showed a 14% relative risk ...

New research shows that, in spite of recommendations discouraging use of aspirin in primary prevention of cardiovascular disease among older adults, nearly a third of adults 60 years and older are ...

Research from a Monash University-led team has confirmed 2018 research that found healthy older adults who took a low-dose of aspirin daily experienced a higher risk of a major hemorrhage without any ...

A new study shows that people who develop type 1 diabetes in adulthood have an increased risk of cardiovascular disease and death, and that those diagnosed later in life do not have a better prognosis ...

A new study found that young adults in good cardiovascular health tended to maintain it as they got older. Studio Firma/Stocksy United Building healthy heart habits early in life is essential to ...

A recent study explores how a simple dietary addition may influence cardiovascular function in individuals with prediabetes.